IDV vehicle
36E79722D0025
NEW AWARD FOR ACETAZOLAMIDE TABLETS WITH AVKARE. ORDERING PERIOD IS JULY 31, 2022 TO JULY 30, 2023 WITH FOUR ONE-YEAR OPTIONS
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Veterans Affairs |
| Office | NAC PHARMACEUTICALS (36E797) |
| NAICS | 325412 — Pharmaceutical Preparation Manufacturing |
| PSC | 6505 — Drugs and Biologicals |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $0 |
| Current contract value | Not reported |
| Potential contract value / ceiling | $2.1M |
| Start date | Jul 31, 2022 |
| Current end date | Not available |
| Potential end date | Not available |
| Latest award activity | Sep 1, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 12 of 12 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Sep 1, 2026 | P00011 | $0 | IMPLEMENTING EO 14398 DEI DISCRIMINATION |
| Jun 23, 2026 | P00010 | $0 | EXERCISE THE FOURTH OPTION YEAR FOR ACETAZOLAMIDE TABLETS, CONTRACT 36E79722D0025, WITH AVKARE, LLC WITH NO PRICE CHANGES. |
| Dec 11, 2025 | P00009 | $0 | INCORPORATE AVKARE'S 2026 SUBK PLAN INTO CONTRACT. PLAN EFFECTIVE 1/1/2026 - 12/31/2026. |
| Jul 10, 2025 | P00008 | $0 | EXERCISE THE THIRD OPTION YEAR FOR ACETAZOLAMIDE TABLETS CONTRACT 36E79722D0025 WITH AVKARE, LLC WITH NO PRICE CHANGES. |
| Jan 3, 2025 | P00007 | $0 | INCORPORATE AVKARE'S 2025 SUBK PLAN INTO CONTRACT. PLAN EFFECTIVE 1/3/2025 - 12/31/2025. |
| Jun 27, 2024 | P00006 | $0 | EXERCISE THE SECOND OPTION YEAR FOR ACETAZOLAMIDE TABLETS CONTRACT 36E79722D0025 WITH AVKARE, LLC WITH NO PRICE CHANGES. |
| Feb 20, 2024 | P00005 | $0 | UPDATE TO COST RECOVERY FEE (CRF) AND SUBMISSION OF QUARTERLY SALES REPORTS 36E79722D0025, AVKARE, LLC FOR ACETAZOLAMIDE TABLETS. |
| Dec 11, 2023 | P00004 | $0 | IMPLEMENT AVKARE, LLC 2024 SUBK PLAN. |
| Jun 29, 2023 | P00003 | $0 | EXERCISE THE FIRST OPTION YEAR FOR ACETAZOLAMIDE TABLETS CONTRACT 36E79722D0025 WITH AVKARE, LLC WITH NO PRICE CHANGES. |
| Apr 14, 2023 | P00002 | $0 | INCORPORATE UPDATED DSCSA LANGUAGE AND REQUIREMENTS INTO VA NATIONAL CONTRACT 36E79722D0025. |
| Nov 15, 2022 | P00001 | $0 | FAR 52.219-9 SMALL BUSINESS SUBCONTRACTING PLAN. IMPLEMENT AVKARE, LLC 2023 SUBK PLAN. |
| May 31, 2022 | 0 | $0 | NEW AWARD FOR ACETAZOLAMIDE TABLETS WITH AVKARE. ORDERING PERIOD IS JULY 31, 2022 TO JULY 30, 2023 WITH FOUR ONE-YEAR OPTIONS |
Buyer contacts from matching notices
Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.